Sign In Get Started

Hims & Hers Health, Inc. (HIMS) — AI Powered Stock Analysis

Data as of March 23, 2026 Try Free

Hims surges on telehealth innovation but GLP-1 regs threaten core growth engine

Company Snapshot

HIMS Hims & Hers Health, Inc.
$22.46
Healthcare

Hims & Hers Health, Inc. is a telehealth platform connecting consumers to licensed healthcare professionals for personalized treatments in sexual health, hair loss, weight management, dermatology, mental health, and more.

Mkt Cap $5.12B
P/E 44.04
52w Range $13.74 — $70.43
Revenue Mix: Online 98% · Wholesale 2%
Analysts: 3 Buy · 13 Hold · 1 Sell  PT $31.29
Competitors: TDOC · AMWL · GDRX Next Earnings: May 4, 2026 (estimated)

Executive Brief

The bull case for Hims & Hers rests on explosive subscriber growth to over 2.5 million, robust 59% revenue expansion to $2.35B in 2025, and a diversified platform spanning weight loss, sexual health, and new specialties like hormone therapy, with 2026 guidance of $2.7-2.9B signaling sustained momentum amid international expansion. Management's execution in personalized treatments and tech infrastructure positions it to capture massive TAMs, targeting $6.5B revenue by 2030. The bear case highlights vulnerability from regulatory crackdowns on compounded GLP-1s, including FDA warnings, DOJ probes, and Novo Nordisk lawsuits, which triggered a 70% stock plunge and Q1 2026 headwinds of $65M.

Key risks include potential bans on weight loss offerings, eroding a growth accelerant while competition from branded drugs intensifies pricing pressure.

Recent Catalysts

  1. Novo Nordisk deal: sells Wegovy/Ozempic, drops lawsuit
  2. Announces $1.15B Eucalyptus acquisition for global expansion
  3. Strategic shift in US weight loss business

Key Risks

  1. FDA/DOJ bans on compounded GLP-1s
  2. Novo Nordisk patent lawsuits
  3. Regulatory scrutiny on telehealth

Full Research Report

1 Business Model
2 Management & Governance
3 Financials
4 Valuation
5 Risk Assessment
Sign up free to unlock full report
Ask about HIMS
Analyst

I've analyzed Hims & Hers Health, Inc.. Click a question below, or sign up free to chat and ask your own.

Sign up free to chat and ask your own questions
This analysis is AI-powered and for informational purposes only. It does not constitute financial advice. Always do your own research before making investment decisions.